Staging Practices for Chronic Graft-vs-Host Disease

Hana Safah, MD, reviews the NIH staging system for graft-vs-host disease and discusses the importance of staging in determining prognosis and informing treatment decisions.

Related Content:

Advancements and New Treatment Options: Optimizing Care for Patients with Graft-vs-Host DiseaseTulane Cancer CenterDana-Farber Cancer InstituteHematologic OncologyInsights

PROs, Gene Expression Vary Among Patients With AML Undergoing Induction Chemo

Multidisciplinary BiTE-Associated AE Education Increases the Safety of Outpatient Administration

Dr Andorsky on Molecular Responses With Second-Line Asciminib in CP-CML